Health Care Technology
Company Overview of GenoLogics Life Sciences Software, Inc.
GenoLogics Life Sciences Software, Inc. provides laboratory information management system (LIMS) software for the management of genomics laboratory samples, tests, and results. It offers Clarity LIMS that provides workflow tracking and integration, automation for complex and mundane tasks, production ready workflows, management reporting functionality, support for regulatory compliance, and role-based interfaces for genomics and mass spec laboratories. The company also provides customer support and technical services; Application Programming Interface Community to provide customers with the opportunity to extend and customize the LIMS for their laboratory environment; and project and impleme...
4464 Markham Street
Victoria, BC V8Z 7X8
Founded in 2002
Key Executives for GenoLogics Life Sciences Software, Inc.
Chief Executive Officer and Director
Vice President of Finance and Operations
Vice President of Product Development
Compensation as of Fiscal Year 2013.
GenoLogics Life Sciences Software, Inc. Key Developments
GenoLogics Announces No-Cost Clarity Cloud Edition
Oct 15 13
GenoLogics Life Sciences Software announced the availability of three new cloud-based lab management products: Clarity Run Manager, Clarity Run Manager Plus, and the early access availability of Clarity LIMS Silver. These editions are sized and priced to fit any genomics laboratory's budget (including a no-cost version), with virtually instantaneous deployment. These editions provide sample management and workflow tracking to support the use of Illumina(R) or Life Technologies(TM) sequencing instruments or other genomics technologies. The advent of desktop sequencing has allowed small and mid-sized labs to routinely provide sequencing services; however, until now there were limited options for project, sample, and lab activity tracking. While most lab managers and directors of these organizations would agree that they should have a LIMS for their next generation sequencing (NGS) tests or services, most do not have such a system due to the high-cost and complexity of traditional commercial tools and/or the lack resources for internal development, implementation and maintenance. The three Clarity Cloud editions provide these organizations access to flexible price and feature set options that can grow with a lab, are easy to use by staff, and require no internal IT resources to configure, update or maintain. The products range in price from the no-cost edition, Clarity Run Manager, to the moderately priced wider LIMS feature set found in Clarity LIMS Silver edition.
Peter MacCallum Cancer Centre Implements GenoLogics Life Sciences Software's Clarity LIMS
Mar 12 13
GenoLogics Life Sciences Software, Inc. announced that the Peter MacCallum Cancer Centre in Melbourne Australia has selected Clarity LIMS to support their next-generation sequencing (NGS) workflows in cancer care.
Illumina Clinical Services Laboratory Signs Subscription License Agreement with GenoLogics Life Sciences Software, Inc. for Clarity LIMS
Feb 25 13
GenoLogics Life Sciences Software, Inc. announced that the Illumina Clinical Services Laboratory has signed a subscription license agreement for Clarity LIMS. Under the agreement, Clarity LIMS, alongside internally developed systems within the CLIA-certified, CAP-accredited laboratory at Illumina, will be used to support Illumina's TruSight Individual Genome Sequencing (IGS) test. Clarity LIMS is an intuitive lab management system that combines information management essentials for CLIA-certified and other regulated labs with a clear and simple interface. Specifically, Clarity LIMS assists these organizations with workflow enforcement, adherence to standard operating procedures and management of the specific complexities associated with next-generation sequencing (NGS). All of these capabilities can be implemented within a few weeks, making Clarity LIMS unparalleled in the industry.
Similar Private Companies By Industry
Recent Private Companies Transactions
September 19, 2013